Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 1801
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  210nM ΔG°:  -37.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  440nM ΔG°:  -35.9kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  1.00E+3nM ΔG°:  -33.9kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTryptase beta-2(Human)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  1.50E+3nM ΔG°:  -32.9kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  2.30E+3nM ΔG°:  -31.9kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTryptase beta-2(Human)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  9.90E+3nM ΔG°:  -28.3kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  1.50E+4nM ΔG°:  -27.3kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  1.68E+4nM ΔG°:  -27.0kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  2.00E+4nM ΔG°:  -26.6kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetTryptase beta-2(Human)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  2.00E+4nM ΔG°:  -26.6kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  2.10E+4nM ΔG°:  -26.4kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  2.10E+4nM ΔG°:  -26.4kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14169(CA-01 | [amino(4-iodo-1-benzothiophen-2-yl)methyli...)
Affinity DataKi:  3.00E+4nM ΔG°:  -25.6kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTryptase beta-2(Human)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  3.40E+4nM ΔG°:  -25.2kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14170(Benzo[b]thiophene-2-carboxamidine | [amino(1-benzo...)
Affinity DataKi:  5.80E+4nM ΔG°:  -23.9kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  6.30E+4nM ΔG°:  -23.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetSerine protease 1(Bovine)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  8.00E+4nM ΔG°:  -23.1kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetUrokinase-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  9.70E+4nM ΔG°:  -22.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  1.10E+5nM ΔG°:  -22.4kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  3.20E+5nM ΔG°:  -19.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetCoagulation factor X(Human)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  3.60E+5nM ΔG°:  -19.5kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM772(Benzamidine | benzamidine deriv. | [amino(phenyl)m...)
Affinity DataKi:  7.50E+5nM ΔG°:  -17.7kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetProthrombin(Human)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  1.60E+6nM ΔG°:  -15.8kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed
TargetTissue-type plasminogen activator(Human)
Axys Pharmaceutical

LigandPNGBDBM14171([amino(thieno[2,3-b]pyridin-2-yl)methylidene]azani...)
Affinity DataKi:  1.80E+6nM ΔG°:  -15.5kJ/molepH: 7.4 T: 2°CAssay Description:Each enzyme was assayed with a set of different concentrations of each inhibitor. After addition of the appropriate substrate, the rate of hydrolysis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/6/2007
Entry Details Article
PubMed